Wells Fargo’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-37,955
| Closed | -$364K | – | 6715 |
|
|
2024
Q4 | $364K | Buy |
37,955
+6,870
| +22% | +$66K | ﹤0.01% | 3929 |
|
|
2024
Q3 | $88.9K | Buy |
31,085
+3,252
| +12% | +$9.3K | ﹤0.01% | 4689 |
|
|
2024
Q2 | $81.3K | Buy |
27,833
+3,803
| +16% | +$11.1K | ﹤0.01% | 4701 |
|
|
2024
Q1 | $76.7K | Buy |
24,030
+3,084
| +15% | +$9.84K | ﹤0.01% | 4677 |
|
|
2023
Q4 | $70.4K | Buy |
20,946
+4,135
| +25% | +$13.9K | ﹤0.01% | 4701 |
|
|
2023
Q3 | $40K | Sell |
16,811
-8,970
| -35% | -$21.3K | ﹤0.01% | 4947 |
|
|
2023
Q2 | $45.4K | Buy |
25,781
+25,424
| +7,122% | +$44.7K | ﹤0.01% | 5176 |
|
|
2023
Q1 | $1.1K | Sell |
357
-13,994
| -98% | -$43.1K | ﹤0.01% | 6031 |
|
|
2022
Q4 | $76.1K | Buy |
14,351
+21
| +0.1% | +$111 | ﹤0.01% | 4382 |
|
|
2022
Q3 | $50K | Buy |
14,330
+129
| +0.9% | +$450 | ﹤0.01% | 4652 |
|
|
2022
Q2 | $37K | Buy |
14,201
+75
| +0.5% | +$195 | ﹤0.01% | 4893 |
|
|
2022
Q1 | $64K | Sell |
14,126
-32,172
| -69% | -$146K | ﹤0.01% | 5208 |
|
|
2021
Q4 | $315K | Buy |
46,298
+46,166
| +34,974% | +$314K | ﹤0.01% | 4669 |
|
|
2021
Q3 | $1K | Hold |
132
| – | – | ﹤0.01% | 6491 |
|
|
2021
Q2 | $1K | Sell |
132
-4,634
| -97% | -$35.1K | ﹤0.01% | 6425 |
|
|
2021
Q1 | $46K | Buy |
4,766
+3,318
| +229% | +$32K | ﹤0.01% | 5500 |
|
|
2020
Q4 | $16K | Sell |
1,448
-2,718
| -65% | -$30K | ﹤0.01% | 5665 |
|
|
2020
Q3 | $37K | Buy |
+4,166
| New | +$37K | ﹤0.01% | 5348 |
|